0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 41-60 of 932 Articles
JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(6):550. doi:10.1001/jama.2016.0085.

JAMA Oncology | 
Editor's Note |  FREE
Mary L. Disis, MD
JAMA Oncol. 2016;2(2):241. doi:10.1001/jamaoncol.2015.4717.

JAMA Oncology | 
Original Investigation | 
Shelli R. Kesler, PhD; Douglas W. Blayney, MD
JAMA Oncol. 2016;2(2):185-192. doi:10.1001/jamaoncol.2015.4333.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Douglas B. Johnson, MD; Ryan J. Sullivan, MD; Patrick A. Ott, MD, PhD; et al.
JAMA Oncol. 2016;2(2):234-240. doi:10.1001/jamaoncol.2015.4368.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Veronica J. Shi, BA; Anjela Galan, MD; Ian D. Odell, MD, PhD; et al.
JAMA Dermatol. 2016;152(2):222-223. doi:10.1001/jamadermatol.2015.3209.

JAMA Oncology | 
JAMA Oncology Diagnostic Test Interpretation | 
Nibal Rizk, MD; Carlos Kamiya-Matsuoka, MD; Ivo W. Tremont-Lukats, MD
JAMA Oncol. 2016;2(2):265-266. doi:10.1001/jamaoncol.2015.4301.

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

JAMA Neurology | 
Viewpoint | 
Axel Montagne, PhD; Arthur W. Toga, PhD; Berislav V. Zlokovic, MD, PhD
JAMA Neurol. 2016;73(1):13-14. doi:10.1001/jamaneurol.2015.2960.

JAMA Oncology | 
Invited Commentary | 
Rashmi Chugh, MD; Scott M. Schuetze, MD, PhD
JAMA Oncol. 2015;1(9):1280-1281. doi:10.1001/jamaoncol.2015.3221.

JAMA Oncology | 
Original Investigation |  Open Access
Sant P. Chawla, MD; Zsuzsanna Papai, MD; Guzel Mukhametshina, MD; et al.
JAMA Oncol. 2015;1(9):1272-1280. doi:10.1001/jamaoncol.2015.3101.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Rebecca M. Prince, MBBS, FRACP; Eshetu G. Atenafu, MSc, PStat; Monika K. Krzyzanowska, MD, MPH, FRCPC
JAMA Oncol. 2015;1(9):1333-1339. doi:10.1001/jamaoncol.2015.3440.
Includes: Supplemental Content

JAMA Ophthalmology | 
Brief Report | 
Jasmine H. Francis, MD; Brian P. Marr, MD; Scott E. Brodie, MD, PhD; et al.
JAMA Ophthalmol. 2015;133(12):1459-1463. doi:10.1001/jamaophthalmol.2015.3119.

JAMA Oncology | 
Original Investigation | 
Takeo Fujii, MD, MPH; Fanny Le Du, MD; Lianchun Xiao, MS; et al.
JAMA Oncol. 2015;1(9):1311-1318. doi:10.1001/jamaoncol.2015.3062.
Includes: Supplemental Content

JAMA Ophthalmology | 
JAMA Ophthalmology Clinical Challenge | 
Enchun M. Liu, MD; Rithwick Rajagopal, MD, PhD; M. Gilbert Grand, MD
JAMA Ophthalmol. 2015;133(12):1469-1470. doi:10.1001/jamaophthalmol.2015.1957.

JAMA Oncology | 
Invited Commentary | 
Elisabete Weiderpass, MD, MSc, PhD; Harri Vainio, MD, PhD
JAMA Oncol. 2015;1(9):1291-1292. doi:10.1001/jamaoncol.2015.3270.

JAMA Oncology | 
Original Investigation | 
Marcus G. K. Cumberbatch, MBBS, BSc, MSc; Angela Cox, PhD; Dawn Teare, PhD; et al.
JAMA Oncol. 2015;1(9):1282-1290. doi:10.1001/jamaoncol.2015.3209.
Includes: CME, Supplemental Content

JAMA Oncology | 
Editorial | 
Nikhil C. Munshi, MD
JAMA Oncol. 2015;1(8):1035-1036. doi:10.1001/jamaoncol.2015.3015.

JAMA Oncology | 
Original Investigation | 
Ola Landgren, MD, PhD; Youn K. Shim, PhD; Joel Michalek, PhD; et al.
JAMA Oncol. 2015;1(8):1061-1068. doi:10.1001/jamaoncol.2015.2938.

JAMA Psychiatry | 
Viewpoint | 
Ian R. H. Rockett, PhD, MPH; Eric D. Caine, MD
JAMA Psychiatry. 2015;72(11):1069-1070. doi:10.1001/jamapsychiatry.2015.1418.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Original Investigation  | 
Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women A Nationwide Cohort Study
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD
JAMA
Original Investigation  | 
Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain
Wayne A. Ray, PhD; Cecilia P. Chung, MD, MPH; Katherine T. Murray, MD; et al.
JAMA
News From the Centers for Disease Control and Prevention  | 
Counterfeit Norco Poses New Danger